HYBRID EVENT: You can participate in person at Barcelona, Spain from your home or work.

4th Edition of International Heart Congress

June 22-24,2026 | Hybrid Event

June 22 -24, 2026 | Barcelona, Spain

Heart Congress 2026

Miroslav Radenkovic, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Miroslav Radenkovic, University of Belgrade, Serbia

Pulmonary Arterial Hypertension (PAH) is still a devastating illness with substantial morbidity and death outcomes. Taking into account that the disease advances quickly for many patients, and is commonly associated with severe clinical symptoms, new treatment options are still r [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, Personalized and Precision Medicine (PPM). The pace of inno-vation in Personalized & Precision Cardiology (PPC) is thus becoming fast including: The success [....] » Read More

Thomas J Webster, Speaker at Heart Conferences
Keynote Presentation (In-Person)
Thomas J Webster, Hebei University of Technology, China

Nanomedicine, or the use of materials with at least one dimension less than 100 nm, has led to improved disease prevention, diagnosis, and treatment. This talk will cover recent advances in the use of nanomaterials to prevent, diagnose, and treat cardiovascular diseases. Specific [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Catalytic Abs (catAbs) are multivalent Immunoglobulins (Igs) with a capacity to hydrolyze the Antigenic (Ag) substrate. In this sense, proteolytic Abs (Ab-proteases) represent Abs to pro-vide proteolytic effects. Abs against Cardiac Myosin (CM) with proteolytic activity exhibitin [....] » Read More

Federico Benetti, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Federico Benetti, Benetti Foundation, Argentina

Between 1970 and 1980 there were experiences and series of patients operated on Direct Coronary Surgery without the use of extracorporeal circulation. During the 80 and 90 the Technique was developed. The MIDCAB was the one that promoted the development of Coronary Surgery withou [....] » Read More

Agustin Joison, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Agustin Joison, Cordoba Catholic University, Argentina

Introduction: The fibrinolytic activity in human plasma was subsequently shown to depend on activation of a plasminogen as precursor. As plasmin derives from plasminogen, it is possible that microplasmin also has a precursor, microplasminogen. The present study describes the &nbs [....] » Read More

Ishan Abdullah, Speaker at Cardiovascular Diseases Events
Poster Presentation (Virtual)
Ishan Abdullah, George Washington University School of Medicine and Health Sciences, United States

Background: Liver cirrhosis is associated with characteristic Electrocardiographic (ECG) and cardiac structural abnormalities, including QTc prolongation and low voltage. In those with heart disease, these changes are often encompassed under the entity of cirrhotic cardiomyopathy [....] » Read More

Will be updated soon......
Watsapp